Follow
Takaaki Masuda
Takaaki Masuda
九州大学病院別府病院 外科
Verified email at m.kyushu-u.ac.jp
Title
Cited by
Cited by
Year
Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 …
T Masuda, H Inoue, H Sonoda, S Mine, Y Yoshikawa, K Nakayama, ...
Cancer research 62 (13), 3819-3825, 2002
3452002
Advantages of totally laparoscopic distal gastrectomy over laparoscopically assisted distal gastrectomy for gastric cancer
O Ikeda, Y Sakaguchi, Y Aoki, N Harimoto, J Taomoto, T Masuda, T Ohga, ...
Surgical endoscopy 23, 2374-2379, 2009
1842009
Clinical and biological significance of circulating tumor cells in cancer
T Masuda, N Hayashi, T Iguchi, S Ito, H Eguchi, K Mimori
Molecular oncology 10 (3), 408-417, 2016
1572016
Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer
Y Takano, T Masuda, H Iinuma, R Yamaguchi, K Sato, T Tobo, H Hirata, ...
Oncotarget 8 (45), 78598, 2017
1552017
Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma
T Masuda, H Inoue, K Nishida, H Sonoda, Y Yoshikawa, Y Kakeji, ...
Clinical cancer research 9 (15), 5693-5698, 2003
1442003
Decreased expression of fructose-1, 6-bisphosphatase associates with glucose metabolism and tumor progression in hepatocellular carcinoma
H Hirata, K Sugimachi, H Komatsu, M Ueda, T Masuda, R Uchi, ...
Cancer research 76 (11), 3265-3276, 2016
1302016
Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer
K Mimori, Y Tanaka, K Yoshinaga, T Masuda, K Yamashita, M Okamoto, ...
Annals of oncology 15 (2), 236-241, 2004
1172004
MicroRNAs as biomarkers in colorectal cancer
T Masuda, N Hayashi, Y Kuroda, S Ito, H Eguchi, K Mimori
Cancers 9 (9), 124, 2017
1122017
A temporal shift of the evolutionary principle shaping intratumor heterogeneity in colorectal cancer
T Saito, A Niida, R Uchi, H Hirata, H Komatsu, S Sakimura, S Hayashi, ...
Nature communications 9 (1), 2884, 2018
1062018
MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway
K Mimori, T Shiraishi, K Mashino, H Sonoda, K Yamashita, K Yoshinaga, ...
Oncogene 22 (22), 3463-3471, 2003
1002003
Significance of skp2 expression in primary breast cancer.
H Sonoda, H Inoue, K Ogawa, T Utsunomiya, T Masuda, M Mori
Clinical cancer research: an official journal of the American Association …, 2006
862006
N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma
K Yoshinaga, H Inoue, T Utsunomiya, H Sonoda, T Masuda, K Mimori, ...
Clinical cancer research 10 (17), 5702-5707, 2004
802004
Absence of Msh2 protein expression is associated with alteration in the FHIT locus and Fhit protein expression in colorectal carcinoma
M Mori, K Mimori, T Masuda, K Yoshinaga, K Yamashita, A Matsuyama, ...
Cancer research 61 (20), 7379-7382, 2001
722001
New technique for the retraction of the liver in laparoscopic gastrectomy
Y Sakaguchi, O Ikeda, Y Toh, Y Aoki, N Harimoto, J Taomoto, T Masuda, ...
Surgical endoscopy 22, 2532-2534, 2008
692008
Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence
M Ueda, T Iguchi, T Masuda, Y Nakahara, H Hirata, R Uchi, A Niida, ...
Oncotarget 7 (38), 62280, 2016
682016
BRCA1 deficiency impairs mitophagy and promotes inflammasome activation and mammary tumor metastasis
Q Chen, JH Lei, J Bao, H Wang, W Hao, L Li, C Peng, T Masuda, K Miao, ...
Advanced Science 7 (6), 1903616, 2020
592020
Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients
TA Masuda, A Kataoka, S Ohno, S Murakami, K Mimori, T Utsunomiya, ...
International journal of oncology 26 (3), 721-730, 2005
562005
Clinical characteristics of gastric cancer with metastasis to the lymph node along the superior mesenteric vein (14v)
T Masuda, Y Sakaguchi, Y Toh, Y Aoki, N Harimoto, J Taomoto, O Ikeda, ...
Digestive surgery 25 (5), 351-358, 2008
522008
Phase I dose‐escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
T Masuda, M Noda, T Kogawa, D Kitagawa, N Hayashi, T Jomori, ...
Cancer Science 111 (3), 924-931, 2020
512020
Oncogenic splicing abnormalities induced by DEAD‐Box Helicase 56 amplification in colorectal cancer
Y Kouyama, T Masuda, A Fujii, Y Ogawa, K Sato, T Tobo, H Wakiyama, ...
Cancer science 110 (10), 3132-3144, 2019
512019
The system can't perform the operation now. Try again later.
Articles 1–20